Mumbai based health start-up has secured $40m from a funding round led by Novo Holdings and HealthQuad.

The round also saw participation from existing investor Mass Mutual Ventures. will use the funds to support and boost product development for critical care and community diagnostics.

The start-up is also planning to increase its global presence, especially across the US and Europe.

Founded in 2016, the firm’s technology can read and analyse X-rays, CT scans, ultrasounds in less than a minute.’s AI solutions are approved by FDA, CE-certified and evaluated by the World Health Organization.

Its automated medical imaging tools are capable of reducing diagnosis time and help physicians identify critical conditions within minutes to avoid fatalities and to improve quality of patient care, the company said.

Novo Holdings Equity Asia head and senior partner Dr. Amit Kakar said: “We are very pleased to join the outstanding team at and to contribute to their efforts of providing world-class AI solutions in the imaging space, for the benefit of patients worldwide.

“ is at the forefront of transforming diagnostics in both acute and chronic ailments, which is fully aligned with our mission of advancing high-quality and accessible healthcare using innovation and digitization.

Kakar added, “Further, we are excited to connect to our portfolio partners as we see several promising synergies.” CEO and founder Prashant Warier said: “Every year our technology helps more than four million people across 50 countries. Our goal is to continue being bullish in our market expansion, especially in the US and Europe.”

He added, “We are committed to aiding healthcare professionals in diagnosing illnesses faster and with more detail and accuracy while automating most of the routine work.

“This is a win for all involved in healthcare, especially for patients across the globe who will benefit from vastly improved health outcomes.”